Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood lactate dehydrogenase, Blood thyroid stimulating hormone, C-reactive protein, Condition aggravated, Differential white blood cell count
Clinical narrative: WBC low; ESR sed rate elevated; Neutrophils 1183 low; Reports 2 patients received the Pfizer covid 19 vaccine/6 year old; Reports 2 patients received the Pfizer covid 19 vaccine/6 year old; Reports 2 patients received the Pfizer covid 19 vaccine/6 year old; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP, Physician and Other HCP) from medical information team.  A 6 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 04Sep2021 10:55 (Lot number: FD8448) at the age of 6 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Seizures disorder", start date: Aug2020 (ongoing), notes: Status post motor vehicle accident; "Asthma" (ongoing), notes: Provided by caller as past medical history since age 3 years; "Eczema" (unspecified if ongoing), notes: Provided by caller as past medical history since age 3 years; "Febrile" (unspecified if ongoing), notes: Provided by caller as past medical history since age 3 years; "Macular Degeneration left eye" (unspecified if ongoing); "Speech Delay" (ongoing); "Developmental disorder of speech/language" (ongoing); "Macular degeneration", start date: Oct2019 (ongoing), notes: Pertinent Details: Sees optho. Family history included: "positive for asthma" (unspecified if ongoing), notes: Mother, Maternal Grandmother; "Hypertension" (unspecified if ongoing), notes: Maternal Grandmother; "Diabetes" (unspecified if ongoing), notes: Maternal Grandmother; "Allergies" (unspecified if ongoing), notes: Mother. Concomitant medication(s) included: LEVETIRACETAM taken for seizure (ongoing). The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), OVERDOSE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 04Sep2021 10:55, outcome "unknown" and all described as "Reports 2 patients received the Pfizer covid 19 vaccine/6 year old"; WHITE BLOOD CELL COUNT DECREASED (non-serious) with onset 08Oct2021, outcome "unknown", described as "WBC low"; RED BLOOD CELL SEDIMENTATION RATE INCREASED (non-serious) with onset 08Oct2021, outcome "unknown", described as "ESR sed rate elevated"; NEUTROPHIL COUNT DECREASED (non-serious) with onset 08Oct2021, outcome "unknown", described as "Neutrophils 1183 low".  The patient underwent the following laboratory tests and procedures: alanine aminotransferase normal: (08Oct2021) 15, notes: Normal; aspartate aminotransferase: (08Oct2021) 23, notes: Normal; blood thyroid stimulating hormone: (08Oct2021) 257; (08Oct2021) 2.57, notes: Normal; full blood count: (08Oct2021) wbc 4.3 low, notes: WBC Low at 4.3 Neutrophils 1183 low; metabolic function test: (08Oct2021) normal; neutrophil count: (08Oct2021) 1183, notes: Low; platelet count: (08Oct2021) 304,000, notes: Comment: Normal; platelet function test: (08Oct2021) 304,000, notes: Normal; red blood cell sedimentation rate: (08Oct2021) 17, notes: sed rate elevated; thyroxine free: (08Oct2021) 1.0, notes: T4 free 1.0 Normal; white blood cell count: (08Oct2021) 4.3, notes: WBC low at 4.3. Therapeutic measures were not taken as a result of product administered to patient of inappropriate age, overdose, product use issue.  Additional information: 6 years old patient was administered 1 dose of Pfizer Covid-19 Vaccine at doctor's office/urgent care: Product was administered to the patient by a Medical Assistant-she does not think the Medical Assistant knew that the product could only be administered to patients 12 years old and up which would be fault of their staff. This was discovered when the patient came back into the office on 25Sep2021 for their second dose of Pfizer Covid-19 Vaccine. The patient was not administered the second dose of Pfizer Covid-19 Vaccine and the patient was advised that the administration was a mistake as the patient should not have been administered the product while under the age of 12 years-documented as provided by reporter. Caller reported outcome as patient has had no side effects, no adverse events relative to this administration to their awareness, has recovered completely; everything is fine, they just want to be proactive at this time. The patient then came in for their normal physical on 28Sep2021. They advised patient that they would do antibody testing if needed-documented as provided by reporter. . The last time patient was there for a well visit and vaccine was 22Sep2020.  Follow-up attempts are completed. No further information is expected.